drugset / Trial / NCT03258294
Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
This clinical study is a double-blind, randomized, placebo-controlled trial to investigate the effects of melatonin on the sleep disturbance symptoms of Parkinson's disease patients, symptoms which have a significant impact on the quality of life of these patients.
Timeline
- Start
- 2016-01-13
- Primary completion
- 2018-12-30
- Completion
- 2018-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | — | Oral |